New High Blood Pressure Guideline Focuses on Prevention and Early Treatment to Combat CVD Risk
A joint guideline by the American Heart Association and the American College of Cardiology emphasizes early treatment and lifestyle changes to manage high blood pressure, aiming to reduce the risk of cardiovascular diseases and cognitive decline.
The American Heart Association and the American College of Cardiology have released a new guideline aimed at preventing and managing high blood pressure, a condition affecting nearly half of all adults in the U.S. and recognized as the leading preventable risk factor for cardiovascular disease (CVD). The guideline underscores the importance of early intervention through lifestyle modifications and medication to mitigate risks associated with heart attack, stroke, heart failure, kidney disease, cognitive decline, and dementia.
Key recommendations include the use of the American Heart Association’s PREVENTTM risk calculator to assess cardiovascular disease risk, advocating for a heart-healthy diet, physical activity, and stress management. The guideline also highlights the significance of monitoring and treating high blood pressure during pregnancy to prevent complications like preeclampsia.
With high blood pressure being a critical factor in brain health, the guideline advises early treatment for those diagnosed to maintain cognitive function. It also introduces updated medication strategies, including the potential use of GLP-1 medications for patients with high blood pressure and obesity, to achieve blood pressure goals.
The collaborative effort behind this guideline involves 11 other health care organizations, reflecting a comprehensive approach to tackling high blood pressure. By focusing on prevention, early detection, and tailored treatment plans, the guideline aims to improve long-term health outcomes and reduce the burden of cardiovascular diseases and related conditions.